期刊文献+

中药穴位贴敷治疗女性急迫性尿失禁30例 被引量:2

Acupoint Application in Treating 30 Female Patients with Urge Urinary Incontinence
下载PDF
导出
摘要 目的:观察中药穴位贴敷治疗女性急迫性尿失禁的临床疗效。方法:将90例患者随机分为A、B、C 3组,每组30例,A组进行盆底肌训练,B组口服托特罗定,C组中药穴位贴敷,3组疗程均为8周。结果:24小时平均排尿次数3组比较,差异无统计学意义(P>0.05),24小时平均尿失禁次数和平均每次排尿量3组比较,差异有统计学意义(P<0.05)。结论:中药穴位贴敷对于女性急迫性尿失禁具有良好的治疗作用。 Objective: To observe clinical effects of acupoint application in treating women with urge urinary incontinence. Methods: Ninety patients were randomized into three groups: A, B and C, 30 cases each group. Group A accepted pelvic floor muscle training, group B took tolterodine, and group C acupoint application, one course of the treatment was eight weeks. Results: The difference had no statistical meaning in the comparisons of 24 hours average urination times among three groups(P〉0.05), the difference presented statistical meaning in the comparisons of 24 hours average urinary incontinence times and average urinary output each time among three groups(P〈0.05).Conclusion: Acupoint application is effective in treating female urge urinary incontinence.
出处 《西部中医药》 2015年第12期109-110,共2页 Western Journal of Traditional Chinese Medicine
基金 江苏省中医药局科技项目(编号LZ13129)
关键词 尿失禁 急迫性 穴位贴敷 中药 盆底肌训练 托特罗定 urinary incontinence urge acupoint application herbs pelvic floor muscle training tolterodine
  • 相关文献

参考文献6

二级参考文献64

  • 1梁润英,裴晓华,陈永辉,周国琇,高希言,牛学恩.穴位敷贴疗法临床应用近况及展望[J].河南中医,1993,13(1):45-46. 被引量:2
  • 2周炜,王丽平,张树源.穴位贴敷疗法的临床应用[J].中国针灸,2006,26(12):899-903. 被引量:107
  • 3张艳宏.穴位贴敷疗法的理论基础及目前应用现状[J].甘肃中医,2007,20(2):1-3. 被引量:148
  • 4田建平.女性盆底功能障碍性疾病研究进展[J].河北医药,2007,29(2):163-164. 被引量:13
  • 5林昭庚.中西医病名对照大辞典[M].北京:人民卫生出版社,2003:5.
  • 6Nilvebrant L,Andersson KE, Gillberg PG, et al. Tolterodinea new bladder-selective antimuscarinic agent[J]. Eur J Pharmacol, 1997, (327) : 195-207.
  • 7Gillberg PG,Sundquist S , Nilvebrant L. Comparison of the in vitro and in vivo profiles of toherodine with those If subtypeselectie musearinie receptors antagonists[J]. Eur J Pharmacol, 1998, (349) :285-292.
  • 8Hashim H,Abrams P.Drug treatment of overactive bladder:efficacy cost and quality-of-life considerations.Drugs,2004,64:1643-1656.
  • 9Nilvebrant L,Hallen B,Larsson G.Tolterodine,a new bladder selective muscarinic receptor antagonist:Preclinical pharmacological and clinical data.Life Sci,1997,60:1129.
  • 10Chancellor M,Freedman S,Mitcheson HD,et al.Tolerodine,an effective and well tolerated treatment for urge inccnthence and oberactive bladder symptolus.Clin Drag Invest,2000,19:83-91.

共引文献143

同被引文献41

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部